T‐cell response to phytohemagglutinin in the interferon‐γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non‐small cell lung cancer

BACKGROUND: Immune checkpoint inhibitors are a standard treatment for advanced lung cancer, although it remains important to identify biomarkers that can accurately predict treatment response. Immune checkpoint inhibitors enhance the antitumor T‐cell response, and interferon‐γ plays an important rol...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamimaki, Chisato, Kobayashi, Nobuaki, Hirata, Momo, Somekawa, Kohei, Fukuda, Nobuhiko, Kubo, Sousuke, Katakura, Seigo, Teranishi, Shuhei, Watanabe, Keisuke, Horita, Nobuyuki, Hara, Yu, Yamamoto, Masaki, Kudo, Makoto, Piao, Hongmei, Kaneko, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169292/
https://www.ncbi.nlm.nih.gov/pubmed/33943031
http://dx.doi.org/10.1111/1759-7714.13978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169292/
https://www.ncbi.nlm.nih.gov/pubmed/33943031
http://dx.doi.org/10.1111/1759-7714.13978

Ejemplares similares